Rezolute

Yahoo Finance • 16 days ago

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- On December 11, 2025, investors in Rezolute, Inc. (NASDAQ: RZLT) saw the price of their shares crater as much as 90% during intraday trading after the company revealed the failure of its P... Full story

Yahoo Finance • 2 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock... Full story

Yahoo Finance • 2 months ago

Rezolute shares in focus after RA Capital discloses 9.9% stake

* Rezolute (RZLT [https://seekingalpha.com/symbol/RZLT]) said RA Capital has disclosed a 9.9% passive ownership stake in the company, according to a regulatory filing [https://seekingalpha.com/filing/83900961]. * Rezolute (RZLT [https:... Full story

Yahoo Finance • 2 months ago

RZLT: Rezolute, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Rezolute, Inc. (Nasdaq: RZLT) for potential securities law violations. Investors who have lost money in their Rezolute, Inc. investment should contact the firm to... Full story

Yahoo Finance • 3 months ago

Top Midday Decliners

Rezolute (RZLT) reported Thursday that a phase 3 study, evaluating ersodetug in patients with congen PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

INVESTOR ALERT: Investigation of Rezolute, Inc. (RZLT) by Holzer & Holzer, LLC

ATLANTA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Rezolute, Inc. (“Rezolute” or the “Company”) (NASDAQ: RZLT) complied with federal securities laws. On December 11, 2025, Rezolute announced topline... Full story

Yahoo Finance • 3 months ago

BREAKING: Rezolute, Inc. Shares Down Over 85%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

BOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Rezolute, Inc. (Nasdaq: RZLT) for potential securities law violations. Investors who have lost money in their Rezolute, Inc. investment should contact the firm to... Full story

Yahoo Finance • 3 months ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Agape ATP Corporation 363,998,856 0.1229 0.1008 0.1021 +0.0341 VS Media... Full story

Yahoo Finance • 4 months ago

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that it h... Full story

Yahoo Finance • 4 months ago

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

REDWOOD CITY, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that the c... Full story

Yahoo Finance • 4 months ago

Is Rezolute Inc. (RZLT) One of the Top Long-Term Biotechnology Stocks to Buy

Rezolute Inc. (NASDAQ:RZLT) is one of the top long-term biotechnology stocks to buy. Wedbush analyst Yun Zhong reaffirmed a Buy rating on Rezolute Inc. (NASDAQ:RZLT) stock on October 23, citing strong confidence in the company’s lead candi... Full story

Yahoo Finance • 5 months ago

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

REDWOOD CITY, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today reported financial... Full story

Yahoo Finance • 6 months ago

Rezolute Hits 52-Week High On Ersodetug Progress In UpLIFT And SunRIZE Trials For Hyperinsulinism

(RTTNews) - Shares of Rezolute Inc. (RZLT) touched a new 52-week high of $8.06 last week amid FDA alignment on a significantly streamlined clinical development path for its lead asset, Ersodetug, in tumor-induced hyperinsulinism, as well a... Full story

Yahoo Finance • 6 months ago

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that manag... Full story

Yahoo Finance • 6 months ago

Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer

REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced the a... Full story

Yahoo Finance • 7 months ago

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that manag... Full story

Yahoo Finance • 7 months ago

Rezolute posts patient demographics poster for Phase 3 sunRIZE study

Rezolute , Inc. (NASDAQ:RZLT), a $474 million market cap biotech company whose stock has gained over 25% in the past year, announced on Tuesday that it has posted a patient demographic poster related to its ongoing Phase 3 clinical study k... Full story

Yahoo Finance • 7 months ago

Rezolute files to sell 1.3M shares of common stock for holders

* Rezolute (NASDAQ:RZLT [https://seekingalpha.com/symbol/RZLT]) filed to sell 1.3M shares of common stock for holders. * This prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/10198821] MORE ON REZOLUTE... Full story

Yahoo Finance • 8 months ago

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)

REDWOOD CITY, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced that... Full story

Yahoo Finance • 8 months ago

Rezolute ticks higher following disclosure of CFO stock buy

[Shares] Bluberries/iStock via Getty Images * Rezolute is up ~5% in Tuesday afternoon trading following the disclosure of a significant purchase of shares from its CFO. * Daron Evans on Tuesday bought [https://seekingalpha.com/filing/... Full story